Inactivated Veterinary Vaccines Market Report – Research, Industry Analysis Reports and Market Demands

Global Inactivated Veterinary Vaccines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Inactivated Veterinary Vaccines Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Poultry
- 1.3.3 Ruminants
- 1.3.4 Feline
- 1.3.5 Canine
1.4 Market Analysis by Pathogen
- 1.4.1 Overview: Global Inactivated Veterinary Vaccines Consumption Value by Pathogen: 2021 Versus 2025 Versus 2032
- 1.4.2 Viral Live Vaccines
- 1.4.3 Bacterial Live Vaccines
- 1.4.4 Parasitic Live Vaccines
1.5 Market Analysis by Vaccine Combination
- 1.5.1 Overview: Global Inactivated Veterinary Vaccines Consumption Value by Vaccine Combination: 2021 Versus 2025 Versus 2032
- 1.5.2 Monovalent Live Vaccines
- 1.5.3 Multivalent Live Vaccines
- 1.5.4 Combination Live Vaccines
1.6 Market Analysis by Application
- 1.6.1 Overview: Global Inactivated Veterinary Vaccines Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Veterinary Hospital
- 1.6.3 Laboratory
- 1.6.4 CROs
- 1.6.5 Others
1.7 Global Inactivated Veterinary Vaccines Market Size & Forecast
- 1.7.1 Global Inactivated Veterinary Vaccines Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Inactivated Veterinary Vaccines Sales Quantity (2021-2032)
- 1.7.3 Global Inactivated Veterinary Vaccines Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Inactivated Veterinary Vaccines by Manufacturer

3.1 Global Inactivated Veterinary Vaccines Sales Quantity by Manufacturer (2021-2026)
3.2 Global Inactivated Veterinary Vaccines Revenue by Manufacturer (2021-2026)
3.3 Global Inactivated Veterinary Vaccines Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Inactivated Veterinary Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Inactivated Veterinary Vaccines Manufacturer Market Share in 2025
- 3.4.3 Top 6 Inactivated Veterinary Vaccines Manufacturer Market Share in 2025
3.5 Inactivated Veterinary Vaccines Market: Overall Company Footprint Analysis
- 3.5.1 Inactivated Veterinary Vaccines Market: Region Footprint
- 3.5.2 Inactivated Veterinary Vaccines Market: Company Product Type Footprint
- 3.5.3 Inactivated Veterinary Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Inactivated Veterinary Vaccines Market Size by Region
- 4.1.1 Global Inactivated Veterinary Vaccines Sales Quantity by Region (2021-2032)
- 4.1.2 Global Inactivated Veterinary Vaccines Consumption Value by Region (2021-2032)
- 4.1.3 Global Inactivated Veterinary Vaccines Average Price by Region (2021-2032)
4.2 North America Inactivated Veterinary Vaccines Consumption Value (2021-2032)
4.3 Europe Inactivated Veterinary Vaccines Consumption Value (2021-2032)
4.4 Asia-Pacific Inactivated Veterinary Vaccines Consumption Value (2021-2032)
4.5 South America Inactivated Veterinary Vaccines Consumption Value (2021-2032)
4.6 Middle East & Africa Inactivated Veterinary Vaccines Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
5.2 Global Inactivated Veterinary Vaccines Consumption Value by Type (2021-2032)
5.3 Global Inactivated Veterinary Vaccines Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
6.2 Global Inactivated Veterinary Vaccines Consumption Value by Application (2021-2032)
6.3 Global Inactivated Veterinary Vaccines Average Price by Application (2021-2032)

7 North America

7.1 North America Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
7.2 North America Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
7.3 North America Inactivated Veterinary Vaccines Market Size by Country
- 7.3.1 North America Inactivated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 7.3.2 North America Inactivated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
8.2 Europe Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
8.3 Europe Inactivated Veterinary Vaccines Market Size by Country
- 8.3.1 Europe Inactivated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Inactivated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Inactivated Veterinary Vaccines Market Size by Region
- 9.3.1 Asia-Pacific Inactivated Veterinary Vaccines Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Inactivated Veterinary Vaccines Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
10.2 South America Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
10.3 South America Inactivated Veterinary Vaccines Market Size by Country
- 10.3.1 South America Inactivated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 10.3.2 South America Inactivated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Inactivated Veterinary Vaccines Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Inactivated Veterinary Vaccines Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Inactivated Veterinary Vaccines Market Size by Country
- 11.3.1 Middle East & Africa Inactivated Veterinary Vaccines Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Inactivated Veterinary Vaccines Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Inactivated Veterinary Vaccines Market Drivers
12.2 Inactivated Veterinary Vaccines Market Restraints
12.3 Inactivated Veterinary Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Inactivated Veterinary Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Inactivated Veterinary Vaccines
13.3 Inactivated Veterinary Vaccines Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Inactivated Veterinary Vaccines Typical Distributors
14.3 Inactivated Veterinary Vaccines Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Inactivated Veterinary Vaccines market size was valued at US$ 552 million in 2025 and is forecast to a readjusted size of US$ 915 million by 2032 with a CAGR of 8.1% during review period.
In 2025, global Inactivated Veterinary Vaccine approximately 22,364 k doses, with an average global market price of around US$ 24 per dose. Gross margin is about 47%. The cost is 13 usd. The Production is about 25,000 k doses. Inactivated veterinary vaccines are biological products used to prevent animal diseases. They are made from viruses, bacteria, or other pathogens that have been inactivated through chemical, physical, or other methods, so they lose their ability to replicate and cause disease while retaining antigenic structures that can stimulate an immune response in animals. Inactivated veterinary vaccines are generally considered safer because they do not multiply in the host or revert to virulence. They are widely used in disease prevention for poultry, swine, cattle, sheep, companion animals, and aquaculture species. However, because they usually induce a weaker immune response than live attenuated vaccines, they often require adjuvants and may need booster vaccinations.
Inactivated veterinary vaccines will develop toward higher safety, stronger immune efficacy, and more stable manufacturing processes. Since inactivated vaccines cannot replicate in animals, they offer a strong safety profile and will continue to play an important role in disease prevention for poultry, swine, cattle, sheep, companion animals, and aquaculture species. With the growth of large-scale farming and stricter animal disease control requirements, manufacturers will focus more on antigen purification, adjuvant optimization, multivalent combination vaccines, and long-lasting immune protection to improve protection rates, reduce vaccination frequency, and lower disease prevention costs. At the same time, cell culture, suspension culture, automated filling, freeze-drying stability, and cold-chain management technologies will continue to improve, enhancing product consistency, production capacity, and supply reliability.
This report is a detailed and comprehensive analysis for global Inactivated Veterinary Vaccines market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Inactivated Veterinary Vaccines market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Inactivated Veterinary Vaccines market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Inactivated Veterinary Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global Inactivated Veterinary Vaccines market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inactivated Veterinary Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inactivated Veterinary Vaccines market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Ceva Santé Animale, Boehringer Ingelheim Animal Health, MSD Animal Health, Virbac, HIPRA, Vetoquinol, Phibro Animal Health, IDT Biologika, Vaxxinova, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Inactivated Veterinary Vaccines market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Poultry
Ruminants
Feline
Canine
Market segment by Pathogen
Viral Live Vaccines
Bacterial Live Vaccines
Parasitic Live Vaccines
Market segment by Vaccine Combination
Monovalent Live Vaccines
Multivalent Live Vaccines
Combination Live Vaccines
Market segment by Application
Veterinary Hospital
Laboratory
CROs
Others
Major players covered
Zoetis
Ceva Santé Animale
Boehringer Ingelheim Animal Health
MSD Animal Health
Virbac
HIPRA
Vetoquinol
Phibro Animal Health
IDT Biologika
Vaxxinova
KBNP Inc.
China Pharmaceutical Group Animal Health Co., Ltd.
Jinyu Bio-technology Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inactivated Veterinary Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inactivated Veterinary Vaccines, with price, sales quantity, revenue, and global market share of Inactivated Veterinary Vaccines from 2021 to 2026.
Chapter 3, the Inactivated Veterinary Vaccines competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inactivated Veterinary Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inactivated Veterinary Vaccines market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inactivated Veterinary Vaccines.
Chapter 14 and 15, to describe Inactivated Veterinary Vaccines sales channel, distributors, customers, research findings and conclusion.

Buy now